Kasiviswanathan Medical Agencies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 32.50 M
as on 24-10-2024
- Satisfied Charges ₹ 34.34 M
as on 24-10-2024
- Revenue 1.34%
(FY 2023)
- Profit -24.54%
(FY 2023)
- Ebitda -15.04%
(FY 2023)
- Net Worth 6.38%
(FY 2023)
- Total Assets 5.20%
(FY 2023)
About Kasiviswanathan Medical Agencies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.25 Cr. The company has closed loans amounting to ₹3.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Annamalai Alagappan, Lakshmanan Periyakaruppan, and Alagappan Alagammai serve as directors at the Company.
- CIN/LLPIN
U74900TN2014PTC094574
- Company No.
094574
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2014
- Date of AGM
21 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Madurai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kasiviswanathan Medical Agencies?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Annamalai Alagappan  | Managing Director | 13-Jan-2014 | Current |
| Lakshmanan Periyakaruppan | Managing Director | 13-Jan-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alagappan Alagammai | Director | 12-Mar-2020 | Current |
Financial Performance and Corporate Structure Insights of Kasiviswanathan Medical Agencies.
Kasiviswanathan Medical Agencies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.34% increase. The company also saw a substantial fall in profitability, with a 24.54% decrease in profit. The company's net worth moved up by a moderate rise of 6.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kasiviswanathan Medical Agencies?
In 2023, Kasiviswanathan Medical Agencies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Sep 2016 | ₹3.25 Cr | Open |
City Union Bank Limited Creation Date: 07 May 2014 | ₹3.43 Cr | Satisfied |
How Many Employees Work at Kasiviswanathan Medical Agencies?
Kasiviswanathan Medical Agencies has a workforce of 79 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kasiviswanathan Medical Agencies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kasiviswanathan Medical Agencies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
